Cempra (CEMP) IPO Trades Higher
Tweet
Share
E-mailGet Alerts CEMP Hot Sheet
Join SI Premium – FREE
The IPO for Cempra, Inc. (Nasdaq: CEMP) is open for trading. Shares are trading at $6.20 after pricing 8,400,000 shares at $6.
Stifel Nicolaus Weisel, Leerink Swann LLC and Cowen and Company, LLC are serving as joint book-running managers for the offering. Needham & Company, LLC is acting as co-manager.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases.
Stifel Nicolaus Weisel, Leerink Swann LLC and Cowen and Company, LLC are serving as joint book-running managers for the offering. Needham & Company, LLC is acting as co-manager.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases.
Create E-mail Alert Related Categories
IPOsRelated Entities
Stifel, Needham & Company, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
